Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, USA.
Annu Rev Immunol. 2013;31:227-58. doi: 10.1146/annurev-immunol-020711-075005.
Understanding how signals are integrated to control natural killer (NK) cell responsiveness in the absence of antigen-specific receptors has been a challenge, but recent work has revealed some underlying principles that govern NK cell responses. NK cells use an array of innate receptors to sense their environment and respond to alterations caused by infections, cellular stress, and transformation. No single activation receptor dominates; instead, synergistic signals from combinations of receptors are integrated to activate natural cytotoxicity and cytokine production. Inhibitory receptors for major histocompatibility complex class I (MHC-I) have a critical role in controlling NK cell responses and, paradoxically, in maintaining NK cells in a state of responsiveness to subsequent activation events, a process referred to as licensing. MHC-I-specific inhibitory receptors both block activation signals and trigger signals to phosphorylate and inactivate the small adaptor Crk. These different facets of inhibitory signaling are incorporated into a revocable license model for the reversible tuning of NK cell responsiveness.
了解信号如何整合以控制自然杀伤 (NK) 细胞在没有抗原特异性受体的情况下的反应能力一直是一个挑战,但最近的研究揭示了一些控制 NK 细胞反应的基本原理。NK 细胞使用一系列先天受体来感知其环境,并对感染、细胞应激和转化引起的变化做出反应。没有一个单一的激活受体占主导地位;相反,来自受体组合的协同信号被整合以激活自然细胞毒性和细胞因子产生。主要组织相容性复合体 I (MHC-I) 的抑制性受体在控制 NK 细胞反应中起着关键作用,而且矛盾的是,在维持 NK 细胞对随后的激活事件的反应能力方面起着关键作用,这个过程被称为许可。MHC-I 特异性抑制性受体既能阻断激活信号,又能触发信号,使小分子衔接蛋白 Crk 磷酸化和失活。抑制信号的这些不同方面被纳入 NK 细胞反应性的可撤销许可模型中,以实现 NK 细胞反应性的可逆调节。